Masato Nakai

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

Goki Suda, Mineo Kudo, Atsushi Nagasaka et al. · Journal of Gastroenterology · 2016 · 109 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

Fibroblast growth factor-2–mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma

Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka et al. · Carcinogenesis · 2017 · 100 citations · Full text

Medicine, Cancer Biology, Oncology +17

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

Masatsugu Ohara, Koji Ogawa, Goki Suda et al. · Hepatology Communications · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling

Taku Shigesawa, Osamu Maehara, Goki Suda et al. · Carcinogenesis · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16

Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection

Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto et al. · Journal of Gastroenterology · 2020 · 61 citations

Life Sciences, Biochemistry, Pharmacology +13